Prescription marketplace
Modern medicine.
Personalized care.
Explore prescription treatment options, understand the differences, and connect with licensed healthcare professionals who determine what care is appropriate for you.
Wegovy®
semaglutide
Chronic weight management in eligible adults; CV risk reduction in adults with established CVD and obesity/overweight.
Trademark of Novo Nordisk. No affiliation implied.
Start consultation →Zepbound®
tirzepatide
Chronic weight management in eligible adults; moderate-to-severe OSA in adults with obesity.
Trademark of Eli Lilly. No affiliation implied.
Start consultation →Ozempic®
semaglutide
Type 2 diabetes (glycemic control, CV risk reduction). Not approved for weight loss.
Trademark of Novo Nordisk. No affiliation implied.
Start consultation →Mounjaro®
tirzepatide
Type 2 diabetes glycemic control. Not approved for weight loss.
Trademark of Eli Lilly. No affiliation implied.
Start consultation →Metformin
metformin HCl
Type 2 diabetes. FDA-approved generic.
Start consultation →Sildenafil
sildenafil citrate
Erectile dysfunction. FDA-approved generic.
Start consultation →Finasteride
finasteride
Male pattern hair loss (1 mg). FDA-approved generic.
Start consultation →Estradiol
estradiol
Vasomotor symptoms of menopause. FDA-approved generic.
Start consultation →Testosterone cypionate
testosterone cypionate
Confirmed hypogonadism with symptoms and low labs.
Start consultation →Levothyroxine
levothyroxine
Hypothyroidism. FDA-approved generic.
Start consultation →Vitamin D (Rx)
ergocalciferol
Documented vitamin D deficiency.
Start consultation →Topical hair formula
patient-specific
Prepared for an individual patient when clinically justified. Not FDA-approved.
Start consultation →Custom dermatology cream
patient-specific
Prepared for an individual patient's needs. Not FDA-approved.
Start consultation →Metabolic & longevity panel
lab test
Comprehensive biomarker testing ordered by your clinician.
Start consultation →Availability, pricing and eligibility are subject to clinical, pharmacy and state-specific review. A licensed provider decides whether any treatment is appropriate.
Brand | Generic | Compounded
Tap a column to focus it. Generic and compounded are distinct regulatory categories.
| Compare | Brand-name | Generic | Compounded |
|---|---|---|---|
| Regulatory status | FDA-approved (NDA/BLA) | FDA-approved (ANDA) | Not FDA-approved |
| FDA review of safety & efficacy | Yes — clinical trials | Yes — bioequivalence to reference | No |
| Active ingredient | Specified on label | Same as reference brand | Varies by prescription |
| Dosage forms | Manufacturer-approved only | Matches approved reference | Customized by pharmacy |
| Approved indications | On FDA label | Same as reference label | None — prescriber judgment |
| Made by | Brand manufacturer | Generic manufacturer | Licensed compounding pharmacy |
| Pricing | Shown when verified | Shown when verified | Shown when verified |
| Prescription required | Yes | Yes | Yes — patient-specific need |
| Key safety note | Full prescribing info | Full prescribing info | Quality varies; not a generic substitute |